Penn Medicine has been on a multiyear journey to both raise the rates of screening for colorectal cancer and increase uptake of follow up care, with the goal of driving down colorectal cancer death rates and addressing inequities. Right now, colorectal cancer is the second leading cause of cancer death in the U.S., with higher rates in the Black community than any other racial/ethnic group. Black Americans are 20% more likely to get colorectal cancer, and 40% more likely to die of it compared to most other groups, according to the American Cancer Society.